T. Schreiner
17 Papers
T. Schreiner is an academic researcher. The author has contributed to research in topics: Medicine & Disease. The author has an hindex of 2, co-authored 8 publications.
Chat about Author
Papers
The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions
TL;DR: In this article, the role of amyloid beta peptide in Alzheimer's disease is discussed, and new research directions with diagnostic and therapeutic impacts are suggested, based on the most relevant and recent studies published on this topic.
13
SARS-CoV-2 Possible Etiology of Cerebral Venous Thrombosis in a Teenager: Case Report and Review of Literature
Ioana Grigore,Ingrith Miron,Cristina Gavrilovici,Vasile Valeriu Lupu,Dorin Antal,T. Schreiner,Catalin Prazaru,Ancuta Lupu,Felicia Dragan,Ecaterina Grigore +9 more
TL;DR: In this article , the authors present the case of a teenager who, since the debut of SARS-CoV-2 infection, has accused intermittent right side hemicrania, which has become persistent in association with nausea and vomiting since the 5th day of quarantine.
Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer’s Disease
T. Schreiner,Bogdan Ionel Tamba,Cosmin Mihai,A. Lőrinczi,Mihaela Baibarac,Romeo Cristian Ciobanu,Bogdan A. Popescu +6 more
TL;DR: The proposed alumina nanoporous membrane model is safe and could be incorporated into implantable devices for further in vivo experiments and might be an efficient therapeutic approach for Alzheimer’s disease.
Chemiresistors Based on Hybrid Nanostructures Obtained from Graphene and Conducting Polymers with Potential Use in Breath Methane Detection Associated with Irritable Bowel Syndrome
Alexandru F. Trandabat,R. Ciobanu,Oliver Schreiner,T. Schreiner,Sebastian Teodor Aradoaei +4 more
TL;DR: Chemiresistors based on hybrid nanostructures obtained from graphene and conducting polymers exhibit high sensitivity and linearity for methane detection in air.
1
Passive Anti-Amyloid Beta Immunotherapies in Alzheimer’s Disease: From Mechanisms to Therapeutic Impact
T. Schreiner,Cristina Georgiana Croitoru,D. Hodorog,Dan Iulian Cuciureanu +3 more
TL;DR: Passive anti-amyloid immunotherapies target amyloid beta and promote its clearance from the brain, offering a promising avenue for Alzheimer’s disease treatment.
1